Skip to main content
OpenTrials
Completed

NCT Number: NCT01841346

The First Jordanian PCI Registry: Events at 1 Year

The investigators will look at the short- (in hospital) and long- term ( 1 year)outcome in consecutive patients who undergo stent implantation and angioplasty in Jordan.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Percutaneous Coronary Intervention

Age range

18 year–100 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Istishari Hospital

Amman, 11954, Jordan

About this study

  • Voluntary registry of consecutive patients undergoing Percutaneous coronary intervention (PCI).
  • Patients will be treated according to the treating cardiologists' discretion. No randomization of any medication or stent.
  • Baseline data on admission will be collected (cardiovascular risk factors, blood lipids, ect).
  • PCI procedure details and complications will be documented during the index admission.
  • Outcome events (death, MI, revascularization, stent thrombosis) will be evaluated at 1, 6, and 12 months by clinic visits or phone calls.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Consecutive PCI patients
  • Arab nationality

Exclusion criteria

  • less than 18 year of age

Treatment and study plan

Procedure: PCI

Procedure

Other names: PCI (percutaneous coronary intervention)will be performed according to cardiologists discretion, with no randomization of stent types or medications.

Primary outcomes

  1. Cardiovascular mortality

    Time frame: 1 year

    All cases of deaths from cardiovascular causes will be counted at 1 year.

Secondary outcomes

  1. Admission for urgent coronary revascularization

    Time frame: 1 year

    All events of hospital readmission for repeat coronary intervention for acute coronary syndrome from the time of discharge from hospital up to 1 year will be documented.

Other outcomes

  1. Stent thrombosis

    Time frame: 1 year

    All cases of definite/probable/possible stent thrombosis will be documented from the time of stent implantation during the index admission to 1 year.

  2. Baseline risk factors and outcome after 1 year

    Time frame: 1 year

    Several factors at baseline will be evaluated as potential contributors to adverse outcome after one year, including: age, gender, renal impairment, heart failure, CRUSADE bleeding risc score, GRACE risk score, diabetes, multiple risk factors, BMI, and smoking.

  3. Adherence to guidelines in patients undergoing PCI

    Time frame: 1 year

    Using medications (statins, antiplatelets, ACI inhibitors/ARBs, B blockers, etc),and diagnostic and interventional procedures, and reaching target parameters (LDL cholesterol and HbA1c) according to the published guidelines will be evaluated.

Sponsors and collaborators

Lead sponsor

Jordan Collaborating Cardiology Group

Other

Collaborators

  • AstraZeneca

Registry information

Official study title

The First Jordanian Percutaneous Coronary Intervention (PCI) Registry

Acronym: JoPCR1

Important dates

Study start
2013
Primary completion
2015
Study completion
2015
First posted
Apr 26, 2013
Registry last updated
Jan 10, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.